Brightsurf Science News & Current Events

November 12, 2011
Intensive therapy halves kidney disease in type 1 diabetes
Controlling blood glucose early in the course of type 1 diabetes yields huge dividends, preserving kidney function for decades.

Members of the public lack skills, confidence necessary to save lives with CPR, Penn research shows
Even members of the lay public who have received CPR training are confused about how to perform the lifesaving skill and say they don't have confidence in their ability to do it properly, according to a study from the Perelman School of Medicine at the University of Pennsylvania which will be presented today at the American Heart Association's annual Scientific Sessions.

Can Twitter save lives?
Discussion about cardiac arrest on Twitter is common and represents a new opportunity to provide lifesaving information to the public, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

Chinese genomics giant BGI releases latest bioinformatics software and datasets
BGI, the world's largest genomic organization, announces several bioinformatics analysis pipelines and software, including assembly and binning tools, genetic variation software, as well as two cloud-based green solutions for genomic-based research.

Kidney disease care -- what's in store for the future?
Medicare will soon reduce reimbursements to some dialysis facilities, which may lead to closures.

Intensive diabetes therapy protects Type 1 diabetics' kidneys
In the Diabetes Control and Complications Trial, Ian de Boer, M.D., and his team looked to see if intensive diabetes therapy aimed at reducing blood sugar as close to the normal range as possible might protect Type 1 diabetics' kidney function.

Early, intensive therapy for type 1 diabetes prevented kidney disease in long-term study
Maintaining good glucose control early in the course of type 1 diabetes could lessen the long-term risk of kidney disease, as measured by a common test of kidney function.

Which diabetes drug is best for diabetics with kidney disease?
Previous research indicates that the diabetes drugs sitagliptin and glipizide may not cause considerable kidney damage. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to